Navigation Links
New Report Distorts Truth About Pesticides
Date:8/1/2008

WASHINGTON, Aug. 1 /PRNewswire/ -- A report released yesterday by the Center for Public Integrity, "Perils of the New Pesticides," distorts the truth about the health effects of chemicals in pest management products, according to the Consumer Specialty Products Association (CSPA). Of specific concern is the author's misinterpretation of data collected by the U.S. Environmental Protection Agency's incident reporting system related to pyrethrins, natural insecticides produced by certain species of the chrysanthemum plant, and its synthetic counterparts, pyrethroids. By improperly using EPA data and drawing faulty conclusions from it, the report has needlessly caused alarm about both ingredients which have been used in pesticide products for decades.

CSPA points out that EPA's incidence data base can be a useful indicator of the consumer experience with products only to the extent that the data have been carefully evaluated and considered in the context of the limitations of the incident reporting system and with regard to extensive use of the products being studied. CPI took a simplistic approach that failed in this regard.

CSPA further notes that the data includes every type of case represented in raw data form, such as misuse, abuse, and exposures resulting from attempts at self harm such as suicides. No incident is required to undergo investigation, confirmation or validation before being added to the EPA's raw dataset.

"The basic premise behind the author's paper -- that incident data in its raw form is signaling a serious health threat by these ingredients -- is fundamentally flawed," said Chris Cathcart, CSPA President. "There was no evaluation by expert clinical and medical toxicologists to sort out incidents that, under further scrutiny by EPA's team of expert toxicologists and medical professionals, would have been excluded from the raw data set to allow for a meaningful analysis."

In the spirit of cooperation, CSPA facilitated more than ten hours of interview time with nationally recognized scientific and medical experts in the area of pyrethrins, pyrethroids and incidence reporting with the Center for Public Integrity. One of these experts has been involved with the EPA's reporting structure for incident data since its inception. That expert cautioned the author against drawing conclusions from the dataset that simply could not be supported from a scientific and medical basis given its inherent limitations.

"Clearly, the CPI chose not to invest the time and energy necessary to conduct a thorough analysis, and the result is a seriously flawed report that merely serves to spread misinformation about products that have served consumers well for decades," said Cathcart. "Because of their superior safety profile, pyrethrins and pyrethroids have been the replacement ingredients of choice following the removal of chlorpyrifos and other organophosphates from the marketplace. Pyrethrins and pyrethroids have helped to provide public health benefits by controlling pests that can transmit to humans diseases such as Lyme disease and West Nile virus."

About CSPA

The Consumer Specialty Products Association is a non-profit national trade association representing approximately 250 companies engaged in the manufacture, formulation, distribution and sale of hundreds of familiar consumer products. It is organized into seven divisions: Aerosol Products, Air Care, Antimicrobial Products, Cleaning Products, Pest Management Products, Industrial and Automotive Specialty Chemicals, and Polishes and Floor Maintenance. For more information, please visit http://www.cspa.org.


'/>"/>
SOURCE Consumer Specialty Products Association
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Virginia Tech Report Has National Importance
2. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
3. GAO Report Confirms: Medicare Underpays for Anesthesia Services; Nurse Anesthetists Assure Seniors Access to Safe Anesthesia Care
4. Haemacure Reports Third Quarter 2007 Results
5. Report on patients access to cancer drugs uses flawed methods to reached flawed conclusions
6. Biotech Finishes on a High in August, Burrill Report Says
7. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
8. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
9. MDS Reports Third Quarter 2007 Results
10. First New York/New Jersey Health Care Report Card Released
11. Authentidate Holding Corp. to Report Fourth Quarter and Fiscal 2007 Year End Results on Thursday, September 13, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... 27, 2017 , ... EpiGentek , a Farmingdale, NY-based ... RNA methylation “gold rush” with their established portfolio of optimized assay kits that ... or m6A , RNA methylation has received a new burst in interest ...
(Date:3/27/2017)... ... March 27, 2017 , ... The Association ... chain professionals, will hold their first Northeast Regional AHVAP Meeting. For 2017, Dr. ... “Increasingly, supply chain and value analysis professionals have a ‘seat at the table’ ...
(Date:3/27/2017)... Angeles, CA (PRWEB) , ... March 27, 2017 , ... ... men with prostate cancer, including all stages, is more than 95%. Once the cancer ... drastically to less than 30%. To find out how to avoid this latter group, ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... sodium testing methods are complicated and require expert user knowledge. In a live ... method dedicated to the simplified, yet highly accurate, determination of sodium. , It ...
(Date:3/27/2017)... ... 2017 , ... ?Grow Healthy Vending LLC announced today that ... itself and 1800 Vending DBA Healthy You Vending. (Civil No. 1:14-CV-00121-CW/ United States ... that we have now reached a settlement agreement regarding the ongoing lawsuits between ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... Calif. , March 27, 2017  Sanderling ... acquired by Ethicon, a division of Johnson & ... System for the treatment of gastro-esophageal reflux disease ... sphincter augmentation (MSA) technology and the procedure is ... centers. Torax Medical was founded by ...
(Date:3/27/2017)... Israel , March 27, 2017 ... oncology and immunology, announced today that AGI-134, an immunotherapy for ... acquisition of Agalimmune Ltd., will be featured at the upcoming ... in Washington, DC to be held ... ...
(Date:3/27/2017)... 27, 2017 The global ... 16.0 billion by 2025, according to a new study ... chronic diseases is anticipated to be responsible for the ... widens the scope for growth during the forecast period. ... which is highly susceptible to chronic diseases, is presumed ...
Breaking Medicine Technology: